Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Provivi

Provivi
2012 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Series C LATEST DEAL TYPE
$34.2M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of agricultural pest control formulations designed to protect food supplies without toxic residues. The company's formulations transferase enzymes that activate diazo and azide compounds to generate iron-carbenoids and iron-nitrenoids through a mode of activation for efficient synthesis of biopesticides, enabling clients to reduces pest populations and minimizes crop damage.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Agricultural Chemicals
Primary Office
  • 1701 Colorado Avenue
  • Santa Monica, CA 90404
  • United States

+1 (310) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Provivi’s full profile, request a free trial.

Provivi Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C) 05-Jul-2019 $34.2M 000.00 00000 Completed Generating Revenue
7. Later Stage VC (Series B) 19-Sep-2018 000.00 000.00 000.00 Completed Generating Revenue
6. Grant 01-Jan-2018 00000 000.00 Completed Generating Revenue
5. Debt - General 000.00 Completed Generating Revenue
4. Early Stage VC (Series A1) 06-Oct-2016 000.00 000.00 000.00 Completed Startup
3. Grant 01-Jan-2016 00000 000 Completed Startup
2. Grant 15-Dec-2015 $150K $1M Completed Startup
1. Angel (individual) 12-Mar-2015 $1M $1M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Provivi Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B2 0,000,000 00.000000 00.00 00 00 00 00 00.000
Series B1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series A1 3,507,561 $0.000010 $0.17 $2.13 $2.13 1x $2.13 20.03%
Seed 2,200,000 $0.000010 $0.45 $0.45 1x $0.45 12.57%
To view this company’s complete Cap Table, request access »

Provivi Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Syngenta Formerly PE-Backed Basel, Switzerland 00000 000000&0
0000000 Venture Capital-Backed Winchester, United Kingdom 00 000.00 0000000000 0 000.00
0000-0000 00000000 Corporation Tokyo, Japan 00000
0000 Corporation
To view this company’s complete list of competitors, request access »

Provivi Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BASF Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
DuPont Pioneer Corporation Minority 000 0000 000000 0
Kairos Ventures Venture Capital Minority 000 0000 000000 0
Lanx Capital Family Office Minority 000 0000 000000 0
Spruce Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Provivi Executive Team (8)

Name Title Board
Seat
Contact
Info
Pedro Coelho Ph.D Co-Founder & Chief Executive Officer
Paul Kuc Chief Financial Officer
Peter Meinhold Ph.D Co-Founder & Chief Technology Officer
Philip Rollinson Executive Vice President of Sales and Busienss Development
Frances Arnold Ph.D Co-Founder & Board Member

2 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

Provivi Board Members (6)

Name Representing Role Since Contact
Info
Alan Boyce Provivi Board Member 000 0000
Frances Arnold Ph.D Provivi Co-Founder & Board Member 000 0000
Ganesh Kishore Ph.D Spruce Capital Partners Board Member 000 0000
James Demetriades Provivi Board Member 000 0000
Ronald Olson JD Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »